Clinical Trial Update: Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating cetuximab-IRDye 800CW for intraoperative detection of tumors in malignant glioma patients undergoing surgery; study terminated with p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasm
• Malignant Glioma

Drugs mentioned

• Cetuximab-IRDye 800CW

Snippet

Sponsor: Eben Rosenthal | Conditions: Brain Neoplasm, Malignant Glioma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-05-14